• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对弱势群体的成瘾治疗特定项目和药物的可及性:成瘾治疗定位、评估与标准(ATLAS)调查结果

Availability of Specific Programs and Medications for Addiction Treatment to Vulnerable Populations: Results from the Addiction Treatment Locator, Assessment, and Standards (ATLAS) Survey.

作者信息

Oldfield Benjamin J, Chen Kevin, Joudrey Paul J, Biegacki Emma T, Fiellin David A

机构信息

From the Fair Haven Community Health Care, New Haven, CT (BJO); Program in Addiction Medicine, Department of Medicine, Yale School of Medicine, New Haven, CT (BJO, ETB, DAF); Office of Ambulatory Care and Population Health, New York City Health and Hospitals Corporation, New York, NY (KC); Division of General Internal Medicine and Clinical Innovation, New York University Grossman School of Medicine, New York, NY (KC); Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA (PJJ); Department of Emergency Medicine, Yale School of Medicine, New Haven, CT (DAF); and Yale School of Public Health, New Haven, CT (DAF).

出版信息

J Addict Med. 2023;17(4):477-480. doi: 10.1097/ADM.0000000000001158. Epub 2023 Mar 16.

DOI:10.1097/ADM.0000000000001158
PMID:37579115
Abstract

OBJECTIVES

This study aimed to describe addiction treatment facilities by their offerings of medications for alcohol use disorder (MAUD) and/or for opioid use disorder (MOUD), and by their offering services to groups with barriers to care: uninsured and publicly insured, youth, seniors, individuals preferring to receive care in Spanish, and sexual minority individuals.

METHODS

We examined addiction treatment facility survey data in 6 US states. We performed bivariate analyses comparing facilities that offered MAUD, MOUD, and both (main outcomes). We then constructed a multivariable model to identify predictors of offering MAUD, MOUD, or both, including exposures that demonstrate programming for special populations.

RESULTS

Among 2474 facilities, 1228 (50%) responded between October 2019 and January 2020. Programs were offered for youth (30%), elderly (40%), Spanish-speaking (37%), and sexual minority populations (39%), with 58% providing MAUD, 67% providing MOUD, and 56% providing both. Among those providing MAUD, MOUD, or both, a majority (>60% for all exposures) offered programming to vulnerable populations. With Delaware as reference, Louisiana (adjusted odds ratio [aOR], 0.28; 95% confidence interval [CI], 0.12-0.67) and North Carolina (aOR, 0.33; 95% CI, 0.15-0.72) facilities had lesser odds of offering both MAUD and MOUD. All exposures identifying facilities offering treatment to vulnerable groups were associated with offerings of MAUD and/or MOUD except for offerings to youth; these facilities had less odds of offering MOUD (aOR, 0.31; 95% CI, 0.31-0.62).

CONCLUSIONS

There are facility-level disparities in providing MAUD and MOUD by state, and facilities with youth programming have lesser odds of offering MOUD than other facilities.

摘要

目标

本研究旨在通过酒精使用障碍药物治疗(MAUD)和/或阿片类药物使用障碍药物治疗(MOUD)的提供情况,以及为存在护理障碍的群体提供服务的情况来描述成瘾治疗机构,这些群体包括未参保和参加公共保险的人群、青少年、老年人、更喜欢接受西班牙语护理的个体以及性少数群体个体。

方法

我们研究了美国6个州的成瘾治疗机构调查数据。我们进行了双变量分析,比较提供MAUD、MOUD以及两者都提供的机构(主要结果)。然后我们构建了一个多变量模型,以确定提供MAUD、MOUD或两者都提供的预测因素,包括针对特殊人群的项目展示情况。

结果

在2474个机构中,有1228个(50%)在2019年10月至2020年1月期间做出了回应。为青少年(30%)、老年人(40%)、讲西班牙语的人群(37%)和性少数群体(39%)提供了项目,58%的机构提供MAUD,67%的机构提供MOUD,56%的机构两者都提供。在提供MAUD、MOUD或两者都提供的机构中,大多数(所有暴露情况均>60%)为弱势群体提供了项目。以特拉华州为参照,路易斯安那州(调整后的优势比[aOR],0.28;95%置信区间[CI],0.12 - 0.67)和北卡罗来纳州(aOR,0.33;95% CI,0.15 - 0.72)的机构同时提供MAUD和MOUD的可能性较小。除了针对青少年的项目外,所有表明为弱势群体提供治疗的机构暴露情况都与MAUD和/或MOUD的提供有关;这些机构提供MOUD的可能性较小(aOR,0.31;95% CI,0.31 - 0.62)。

结论

在按州提供MAUD和MOUD方面存在机构层面的差异,并且开展青少年项目的机构提供MOUD的可能性比其他机构小。

相似文献

1
Availability of Specific Programs and Medications for Addiction Treatment to Vulnerable Populations: Results from the Addiction Treatment Locator, Assessment, and Standards (ATLAS) Survey.针对弱势群体的成瘾治疗特定项目和药物的可及性:成瘾治疗定位、评估与标准(ATLAS)调查结果
J Addict Med. 2023;17(4):477-480. doi: 10.1097/ADM.0000000000001158. Epub 2023 Mar 16.
2
Adolescent-Serving Addiction Treatment Facilities in the United States and the Availability of Medications for Opioid Use Disorder.美国的青少年成瘾治疗机构和阿片类药物使用障碍药物的可及性。
J Adolesc Health. 2020 Oct;67(4):542-549. doi: 10.1016/j.jadohealth.2020.03.005. Epub 2020 Apr 24.
3
Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.美国住宅治疗环境中阿片类药物使用障碍药物的可及性和使用差异。
JAMA Netw Open. 2020 Feb 5;3(2):e1920843. doi: 10.1001/jamanetworkopen.2019.20843.
4
Availability of Medications for Opioid Use Disorder in Community Mental Health Facilities.社区心理健康机构中阿片类药物使用障碍药物的供应情况。
JAMA Netw Open. 2024 Jun 3;7(6):e2417545. doi: 10.1001/jamanetworkopen.2024.17545.
5
Simulating the experience of searching for LGBTQ-specific opioid use disorder treatment in the United States.模拟在美国寻找 LGBTQ 特定阿片类药物使用障碍治疗的体验。
J Subst Abuse Treat. 2022 Sep;140:108828. doi: 10.1016/j.jsat.2022.108828. Epub 2022 Jun 16.
6
Predictors of Opioid and Alcohol Pharmacotherapy Initiation at Hospital Discharge Among Patients Seen by an Inpatient Addiction Consult Service.住院成瘾咨询服务患者出院时开始阿片类药物和酒精药物治疗的预测因素。
J Addict Med. 2020 Sep/Oct;14(5):415-422. doi: 10.1097/ADM.0000000000000611.
7
Predictors of availability of long-acting medication for opioid use disorder.阿片类药物使用障碍长效药物供应的预测因素。
Drug Alcohol Depend. 2019 Nov 1;204:107586. doi: 10.1016/j.drugalcdep.2019.107586. Epub 2019 Sep 25.
8
Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retention.药师主导的物质使用障碍过渡期护理诊所对出院后药物治疗保留的影响。
J Subst Abuse Treat. 2021 Nov;130:108440. doi: 10.1016/j.jsat.2021.108440. Epub 2021 Apr 28.
9
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.医疗保险受益人的远程医疗服务的接受情况、阿片类药物使用障碍药物的获得和保留情况,以及在 COVID-19 大流行之前和期间的药物治疗过量情况。
JAMA Psychiatry. 2022 Oct 1;79(10):981-992. doi: 10.1001/jamapsychiatry.2022.2284.
10
Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails.美国监狱中妊娠和产后个体阿片类药物使用障碍治疗药物的可及性。
JAMA Netw Open. 2022 Jan 4;5(1):e2144369. doi: 10.1001/jamanetworkopen.2021.44369.